Document is current

Article History

Received: 11 January 2023

Accepted: 8 September 2023

First Online: 13 November 2023

Change Date: 19 April 2025

Change Type: Update

Change Details: The original online version of this article was revised: the authors reported that the statement in the Funding section was incorrectly given.

Declarations

:

: Dr. Pérez has received honoraria for teaching activities by Nestle, unrelated with the topic of the present work. Dr. Cesari and Dr. Inzitari have also received honoraria by Nestlé for presenting at scientific meetings and serving as members of expert advisory boards, unrelated to the present work, and all the authors have no competing interests (financial or non financial), as defined by BMC, or other interests that might be perceived to influence the research, results and/or discussion reported in this paper.

: The + ÀGIL Barcelona program study protocol and all its procedures were approved by the Clinical Research Ethics Committee of the University Institute for Primary Care Research, Jordi Gol i Gorina Foundation (IDIAPJGol), which was created in 1996 by the Catalan Institute of Health (reference number P18/019).

: Ours is a prospective study, all the participants signed and informed consent before enrolling and only those who finished the follow-up were included, those who died during the course of the study were excluded. All methods were performed in accordance with the relevant guidelines and regulations.

: All participants provided written informed consent for study publication that is stated in the informed consent. Data collected has been used in previous studies of the + AGIL program.